Beyond standard peptides, it offers labeled peptides, antibodies, and assay kits that labs rarely find elsewhere
Biomarkers That Strengthen Medical Necessity Documentation Beyond HbA1c, specific biomarkers indicate cardiometabolic dysfunction and support insurance approval arguments
Medication is working as expected Seems to be working well
Full FDA approval, by contrast, requires successful multi-phase clinical trials for a specific indication, which these peptides have not completed
However, the study found compared to the placebo group: Participants treated with semaglutide exhibited a broad pattern of slower biological aging across epigenetic clocks linked to inflammation and blood, brain, heart, kidney, liver and metabolic health